Tagatose to take on the globe

Related tags Gaio tagatose Nutrition Diet pepsi Pepsi max

Arla Foods' new functional ingredient, Gaio tagatose, believed to
enhance toffee and mint flavour and prolong the sweetness delivery
in chewing gum, is to debut in the US market under Pepsi.

Arla Foods' new functional ingredient, Gaio tagatose, is to debut in the US market with the national launch of a new diet Pepsi flavoured slurpee.

The drink to be sold at seven-eleven stores is to be enhanced using Gaio tagatose in combination with other high intensive sweeteners. The new product is claimed to improve the regular taste of a diet beverage, and combined with Erythritol, provide bulk preventing the drink from turning into a block of ice.

The compatibility of Gaio tagatose to a wide variety of healthier food products is likely to see it used in the bakery and snacks and confectionery industries. Believed to enhance toffee and mint flavour and prolong the sweetness delivery in chewing gum, it is also thought to brown easily, adding colour to various bakery and confectionery applications.

The healthy effects of Gaio tagatose are claimed to be ideal for functional products, toothfriendly properties and prebiotic effects. The sweetener is also believed to have no glycemic response making it of high interest to the rapidly growing low-carb market.

Arla Foods Ingredients owns the exclusive rights to produce and commercialise Gaio tagatose based on a co-operation with Nordzucker, which produces the product. This co-operation has now lead to an equal joint venture company, SweetGredients, subject to EU regulatory approval.

Gaio tagatose is approved for use in foods and beverages in the US and Korea. Approval procedures are under way in Australia, New Zealand and Japan while in South America approval procedures are in the initial phase.

Related topics Ingredients

Related news

Related products

show more

What consumers are looking for in alcohol drinks

What consumers are looking for in alcohol drinks

Content provided by ADM | 12-Apr-2024 | Application Note

Are you ready to understand the consumer insights driving the future of the alcoholic beverage market? We've assembled a consumer insights report...

Redefine resilience with IMMUSE

Redefine resilience with IMMUSE

Content provided by Kyowa Hakko (US) | 02-Apr-2024 | White Paper

IMMUSETM is a universal postbiotic — the first of its kind to activate pDC cells for year-round immune support.

Related suppliers

Follow us

Products

View more

Webinars